¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"tertiary calcium phosphate"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 12 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • guaiacol phosphate
    Àλê(ìÝß«)°úÀ̾îÄÝ.
  • high energy phosphate bond
    °í¿¡³ÊÁöÀλ꿰°áÇÕ.
  • histamine acid phosphate
    È÷½ºÅ¸¹Î»ê¼ºÀλ꿰
  • histamine phosphate
    ÀλêÈ÷½ºÅ¸¹Î.
  • phosphate
    Àλ꿰(ìÝß«ç¤).
  • phosphate
    Àλ꿰
  • phosphate buffer
    Àλ꿰¿ÏÃæ¾×
  • phosphate dehydrogenase deficiency
    Àλ꿰ݼö¼ÒÈ¿¼Ò°áÇÌÁõ
  • phosphate diabetes
    Àλ꿰´ç´¢
  • phosphate reabsorption
    Àλ꿰ÀçÈí¼ö
  • potassium dihydrogen phosphate
    ÀλêÀ̼ö¼Ò(ì£â©áÈ)Ä®·ý
  • pyridoxal phosphate
    ÀλêÇǸ®µ¶»ì.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • calcium
    Ä®½·
  • calcium
    Ä®½·
  • calcium alterans
    Ä®½·±³´ë( -ÎßÓÛ).
  • calcium antagonist
    Ä®½·±æÇ×Á¦.
  • calcium balance
    Ä®½·ÆòÇü(¡­øÁû¬)
  • calcium bilirubinate crystal
    ºô¸®·çºó»êÄ®½·°áÁ¤
  • calcium carbonate
    ź»êÄ®½·
  • calcium channel
    Ä®½·Åë·Î( -÷×ÖØ).
  • calcium channel
    Ä®½· Åë·Î(÷×ÖØ)
  • calcium channel antagonist,blocker
    Ä®½·Åë·Î ±æÇ×Á¦( -÷×ÖØ ÑÏù÷ð¥),Â÷´ÜÁ¦(ó´Ó¨ð¥).
  • calcium chloride
    ¿°È­Ä®½·
  • calcium deposit
    ¼®È¸Ä§Âø
  • calcium deposit
    ¼®È¸Ä§Âø.
  • calcium disorder
    Ä®½·Áúȯ
  • calcium gout
    Ä®½·Åëdz(¡­÷Ôù¦).
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • free calcium
    À¯¸®(ë´×î) Ä®½·
  • unionized calcium
    ºñ(Þª)ÀÌ¿ÂÈ­ Ä®½·
  • active phosphate
    Ȱ¼ºÀλ꿰 (üÀàõ ×òß«ç¤)
  • carbamoyl phosphate
    Ä«¸£¹Ù¸ðÀÏÀλ꿰(×òß«ç¤)
  • creatine phosphate
    Å©·¹¾ÆÆ¾ Àλê(×òß«) (ÔÒ) phosphocreatine
  • dolichol phosphate
    Àλê(×òß«)µ¹¸®ÄÝ
  • fructose-6-phosphate
    ÇÁ¶ôÅ佺-6-Àλê(×òß«)
  • glucose-6-phosphate
    ±Û·çÄÚ½º-6-Àλê(×òß«)
  • glucose-6-phosphate dehydrogenase
    ±Û·çÄÚ½º-6-Àλê(×òß«) µðÇÏÀ̵å·ÎÀú³×À̽º
  • glucose-6-phosphate dehydrogenase deficiency
    ±Û·çÄÚ½º-6-Àλê(×òß«) µðÇÏÀ̵å·ÎÀú³×À̽º °áÇÌ(ÌÀ
  • glycerol phosphate shuttle
    ±Û¸®¼¼·ÑÀλê(×òß«) ºÐ·Î(ÝÂÖØ)
  • high-energy phosphate donor
    °í(ÍÔ)¿¡³ÊÁö ÀÎ»ê°ø¿©ÀÚ(×òß«Íêæ¨í­)
  • inorganic phosphate
    ¹«±âÀλê(ÙíѦ×òß«)
  • labile phosphate group
    ºÒ¾ÈÁ¤Àλê±â(ÝÕäÌïÒ×ò߫Ѩ)
  • nicotinamide adenine dinucleotide phosphate
    ", ´ÏÄڴѾƸ¶ÀÌµå ¾Æµ¥´Ñ ÀÌ(ì£) ´©Å¬·¹¿ÀŸÀ̵å Àλê(×òß«)"
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
CPPD Calcium Pyro-Phosphate Dihydrate
BCP basic calcium phosphate; birth control pill; blue cone pigment; Blue Cross Plan; bromcresol purple
CPD calcium pyrophosphate deposition; cephalopelvic disproportion; cerebelloparenchymal disorder; childh...
G3P, G-3-P glyceraldehyde-3-phosphate; glycerol-3-phosphate
GPD glucose-6-phosphate dehydrogenase; glycerol-phosphate dehydrogenase
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
BCP Basic calcium phosphate
CPC Calcium Phosphate Cement
Ca,P Calcium phosphate
CPC Calcium phosphate ceramic
OCP Octa-calcium phosphate
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • phosphate buffered saline
    Àλ꿰 ½Ä¿°¼ö
  • phosphate depletion
    Àλ꿰 °í°¥
  • sodium phosphate
    ÀÎ»ê ³ªÆ®·ý
    µ¿ÀǾî=disodium hydrogen
  • tricalcium phosphate
    Á¦ 3Ä®½· Àλ꿰
  • zephiran-trisodium phosphate
    Á¦ÇǶõ-Æ®¸®¼Òµð¿ò ÀÎ»ê ¿°
  • zinc phosphate
    ÀÎ»ê ¾Æ¿¬
  • zinc phosphate cement base
    ÀÎ»ê ¾Æ¿¬ ½Ã¸àÆ® ÀÌÀå
    ÀÎ»ê ¾Æ¿¬ ½Ã¸àÆ®¸¦ »ç¿ëÇÏ¿© Ä¡¾Æ¿¡ Çü¼ºÇÑ ¿Íµ¿¿¡ base¸¦ ±î´Â °Í.
  • calcium
    Ä®½·
    »ýü Áß¿¡¼­ °¡Àå ´Ù·®À¸·Î ÇÔÀ¯µÈ ¹«±â ¹°Áú. 99% ÀÌ»óÀÌ »À³ª Ä¡¾Æ µî °æÁ¶Á÷¿¡ Á¸ÀçÇÏ¸ç °ñ°ÝÀÇ À¯Áö ¹× Ä®½·ÀÇ ÀúÀå°í·Î¼­ ÀÛ¿ë. °ÅÀÇ ¸ðµç À¯±â Á¶Á÷ ³»¿¡ µé¾î ÀÖ´Â Áß¿ä ¿ø¼Ò. Ç÷¾× ÀÀ°íÀÇ ¿©·¯ ´Ü°è¿¡¼­ Áß¿äÇÑ ¿ªÇÒÀ» Çϰí Àֱ⠶§¹®¿¡ ÀÀ°í ÀÎÀÚ ¥³¶ó°í ºÒ·Á ¿Ô´Ù.
  • calcium balance
    Ä®½· ÆòÇü
    ü³»ÀÇ Ä®½· ³óµµ°¡ ¾ÈÁ¤µÇ¾î ÀÖ´Â »óÅÂ.
  • calcium channel
    Ä®½· ä³Î
    Ä®½·ÀÌ Åë°úÇÏ´Â µµ°ü.
  • calcium channel blocker
    Ä®½· Åë·Î ºÀ¼â ¾à¹°, Ä®½· Åë·Î Â÷´Ü ¾à¹°, Ä®½· ä³Î Â÷´ÜÁ¦
    µ¿ÀǾî=calcium channel blocking drug. 1. Ä®½·ÀÌ Åë°úÇÏ ´Â µµ°üÀ» ¸·´Â ¾à¹°. 2. Ç× Çù½ÉÁõ Á¦Á¦, Ç×°íÇ÷¾Ð Á¦Á¦, Ç× ºÎÁ¤¸Æ Á¦Á¦·Î »ç¿ëµÇ´Â ¾à¹°·Î½á, µ¿¸ÆÀÇ ÆòȰ±Ù¿¡¼­ Ä®½·ÀÇ À¯ÀÔÀ» Â÷´ÜÇÔÀ¸·Î½á ¸»ÃÊ ¼Òµ¿¸ÆÀ» ÀÌ¿ÏÇØ¼­ ½É±ÙÀÇ »ê¼Ò ¿ä±¸·®À» ÀúÇϽÃŰ´Â ±â´ÉÀ» ÇÑ´Ù. ´ëÇ¥ÀûÀÎ ¾à¹°·Î´Â, vera
  • calcium channel blocking drug
    Ä®½· Åë·Î ºÀ¼â ¾à¹°, Ä®½· Åë·Î Â÷´Ü ¾à¹°
  • calcium deposit
    ¼®È¸ Ä§Âø
    Ä¡°ú¿¡¼­ Ä¡¾Æ Ç¥¸é¿¡ Á¡ÂøµÇ¾î ÀÖ´Â °æ¼º ¶Ç´Â ¿¬¼ºÀÇ ¹°Áú.
  • calcium gluconate
    ±Û·çÄÜ »ê Ä®½·
    ±Û·çÄÜ »êÀÇ Ä®½·¿°. ¹«Ãë ¹«¹ÌÀÇ ¹é»ö °áÁ¤¼º °ú¸³ ¶Ç´Â ºÐ¸». Ä®½· º¸±Þ¿¡ Á¤Á¦ ¶Ç´Â ¾×ÀÌ »ç¿ëµÈ´Ù. ºÒÈ­¹°À̳ª ¼ö»ê Áßµ¶¿¡ ´ëÇÑ °æ±¸ ÇØµ¶Á¦ÀÌ´Ù.
  • calcium gout
    Ä®½· Åëdz
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
tertiary egg membrane See: egg membrane.
(05 Mar 2000)
tertiary medical care Specialised consultative care, usually on referral from primary or secondary medical care personnel, by specialists working in a centre that has personnel and facilities for special investigation and treatment.
(05 Mar 2000)
tertiary oesophageal contractions <radiology> Disordered up-and-down movement of bolus, 5-10% of normal adults in 4-6th decade, location: distal 2/3 of oesophagus aetiology: presbyesophagus, diffuse oesophageal spasm, hyperactive achalasia, neuromuscular disease: diabetes, Parkinsonism, ALS, MS, thyrotoxic myopathy, myotonic dystrophy, obstruction of cardia: neoplasm, distal oesophageal stricture, benign lesion, surgery (repair of HH) findings: spontaneous repetitive nonpropulsive contraction (yo-yo motion), corkscrew appearance, compartmentalization of barium (rosary bead, shish kebab)
(12 Dec 1998)
tertiary structure <biochemistry, chemistry> The third level of structural organisation in a macromolecule.
The primary structure of a protein (for example) is the amino acid sequence, the secondary structure is the folding of the peptide chain (alpha helical or beta pleated), the tertiary structure is the way in which the helices or sheets are folded or arranged to give the three dimensional structure of the protein. Quaternary structure refers to the arrangement of protomers in a multimeric protein.
(13 Jan 1998)
tertiary syphilid A syphilitic skin lesion characteristic of the third stage of the disease.
(05 Mar 2000)
tertiary syphilis <microbiology> An advanced (stage III) syphilitic infection (Treponema pallidum) affecting nervous structures.
Symptoms include ataxia, dementia and tabes dorsalis (staggering gait and postural difficulties).
(13 Jan 1998)
tertiary villus The definitive chorionic villus with a vascular core separated from maternal blood by connective tissue, cytotrophoblast, and syncytiotrophoblast.
(05 Mar 2000)
tertiary vitreous Vitreous fibrils derived from the neuroepithelium of the ciliary body and forming the ciliary zonule.
(05 Mar 2000)
benzoylpas calcium 4-Benzamidosalicylic acid calcium salt;an antituberculous agent.
(05 Mar 2000)
calcium <element> An element taken in through the diet that is essential for a variety of bodily functions, such as neurotransmission, muscle contraction and proper heart function. Imbalances of calcium can lead to many health problems and excess calcium in nerve cells can cause their death.
(22 May 1997)
calcium-45 <radiobiology> Most easily available of the radioactive calcium-45 isotopes; beta-emitter with a half-life of 162.7 days; used as a tracer.
(05 Mar 2000)
calcium-47 <radiobiology> A radioisotope of calcium with a half-life of 4.54 days, used in the diagnosis of disorders of calcium metabolism.
(05 Mar 2000)
calcium alginate A topical haemostatic.
(05 Mar 2000)
calcium aminosalicylate The calcium salt of p-aminosalicylic acid, with the same uses.
(05 Mar 2000)
calcium antagonist calcium channel-blocking agent
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á